Global Spinal Cord Peptidome Profiling in Response to Osteoarthritis in Rats
Ontology highlight
ABSTRACT: Osteoarthritis (OA) is a complex and increasingly prevalent condition affecting an estimated 600 million people worldwide, significantly diminishing quality of life. Understanding OA as both an inflammatory and neurological disease presents challenges for treatment, with no approved disease-modifying therapies available. The neuroactive effects of OA pain on neuropeptide systems, particularly within the spinal cord, remain underexplored, impeding therapeutic advances. Here, we employed mass spectrometry (MS) to characterize the spinal cord peptidome in a validated rat model of OA pain. Peptidome was analyzed at different time points in the Montreal Induction of Rat Arthritis Testing (MI-RAT©; n = 20) model compared to arthrotomic group (Sham; n = 4) and healthy group (Naive; n = 9). Label-free peptidome profiling using liquid chromatography coupled with tandem MS (LC-MS/MS) revealed dynamic changes in endogenous peptides following OA progression, leading to the identification of 624 peptides derived from 29 prohormone precursors. Our findings indicate substantial changes in peptide levels in the spinal cord, particularly involving neuropeptide substance P and peptides derived from proenkephalin, calcitonin gene-related peptide, and somatostatin. These data offer novel insights into the molecular mechanisms underlying OA-associated pain and highlight potential targets for new therapeutic interventions to treat neurochronic pain conditions.
INSTRUMENT(S):
ORGANISM(S): Rattus Norvegicus (rat)
TISSUE(S): Spinal Cord
DISEASE(S): Osteoarthritis
SUBMITTER:
Gaoyuan Lu
LAB HEAD: Lingjun Li
PROVIDER: PXD060558 | Pride | 2025-10-28
REPOSITORIES: Pride
ACCESS DATA